SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-162980
Filing Date
2023-06-08
Accepted
2023-06-08 06:31:06
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d398409ds3.htm S-3 473926
2 EX-4.3 d398409dex43.htm EX-4.3 273202
3 EX-4.5 d398409dex45.htm EX-4.5 92816
4 EX-4.6 d398409dex46.htm EX-4.6 96117
5 EX-4.7 d398409dex47.htm EX-4.7 85511
6 EX-5.1 d398409dex51.htm EX-5.1 28746
7 EX-23.1 d398409dex231.htm EX-23.1 2322
8 EX-FILING FEES d398409dexfilingfees.htm EX-FILING FEES 69704
9 GRAPHIC g398409g04a04.jpg GRAPHIC 58541
10 GRAPHIC g398409g0606055156847.jpg GRAPHIC 2537
  Complete submission text file 0001193125-23-162980.txt   1207777
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272509 | Film No.: 231000623
SIC: 2834 Pharmaceutical Preparations